Skip to main content
Log in

Experimental Acute Pancreatitis-Induced Lung Injury—Prevented with “Cytoflavin®”

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Severe acute pancreatitis represents about 20% of all pancreatitis diagnosis and it has a high mortality rate when associated with a lung dysfunction. The aim of this research was to investigate the use of a wild spectrum metabolic drug (Cytoflavin®) for the treatment of acute lung injury in experimental pancreatitis. A l-arginine-induced acute pancreatitis (groups II and III) was simulated experimentally in a rat population. A combined metabolic drug was used as treatment. We determined the levels of amylase, medium molecules (MM 254 and 280), malonic aldehyde (MA), diene conjugates (DC), interleukin-8 (IL-8), interleukin-10 (IL-10), and tumor necrosis factor-α (TNF-α) in the blood and we performed a histologic examination of the lungs and pancreas of the rat population. The activation of lipid peroxidation peaks at 24–48 h from the onset of the disease. The level of malonic aldehyde in groups II and III was higher (39.09% and 30.99%, respectively) than that in the control group I (p < 0.02; p < 0.01), the diene conjugates level was higher by 43.66% and 42.03% respectively (p < 0.01). With medical correction after 72 h (group III), the level of malonic aldehyde and diene conjugates decreased by 17.0% and 30.5% when compared with group II (no medical correction) (p < 0.05). The level of medium molecules peaked after 72 h of the disease induction (p < 0.001). A correlation was established between the level of endogenous intoxication with the membrane-destructive processes in the lung tissue 48 h after modeling of acute experimental pancreatitis. The use of the proposed medicament correction reduces the manifestations of endogenous intoxication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Yadav D, Lowenfels AB (2013) The epidemiology of pancreatitis and pancreatic cancer. Gastroenterol. 144:1252–1261

    Article  Google Scholar 

  2. Párniczky A, Lantos T, Tóth EM, Szakács Z, Gódi S, Hágendorn R, Illés D, Koncz B, Márta K, Mikó A, Mosztbacher D, Németh BC, Pécsi D, Szabó A, Szücs Á, Varjú P, Szentesi A, Darvasi E, Erőss B, Izbéki F, Gajdán L, Halász A, Vincze Á, Szabó I, Pár G, Bajor J, Sarlós P, Czimmer J, Hamvas J, Takács T, Szepes Z, Czakó L, Varga M, Novák J, Bod B, Szepes A, Sümegi J, Papp M, Góg C, Török I, Huang W, Xia Q, Xue P, Li W, Chen W, Shirinskaya NV, Poluektov VL, Shirinskaya AV, Hegyi PJ, Bátovský M, Rodriguez-Oballe JA, Salas IM, Lopez-Diaz J, Dominguez-Munoz JE, Molero X, Pando E, Ruiz-Rebollo ML, Burgueño-Gómez B, Chang YT, Chang MC, Sud A, Moore D, Sutton R, Gougol A, Papachristou GI, Susak YM, Tiuliukin IO, Gomes AP, Oliveira MJ, Aparício DJ, Tantau M, Kurti F, Kovacheva-Slavova M, Stecher SS, Mayerle J, Poropat G, Das K, Marino MV, Capurso G, Małecka-Panas E, Zatorski H, Gasiorowska A, Fabisiak N, Ceranowicz P, Kuśnierz-Cabala B, Carvalho JR, Fernandes SR, Chang JH, Choi EK, Han J, Bertilsson S, Jumaa H, Sandblom G, Kacar S, Baltatzis M, Varabei AV, Yeshy V, Chooklin S, Kozachenko A, Veligotsky N, Hegyi P, Hungarian Pancreatic Study Group (2019) Antibiotic therapy in acute pancreatitis: from global overuse to evidence-based recommendations. Pancreatology 19(4):488–499. https://doi.org/10.1016/j.pan.2019.04.003

    Article  PubMed  Google Scholar 

  3. Yokoe M, Takada T, Mayumi T (2015) Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. J Hepatobiliary Pancreat Sci 22(6):405–432

    Article  Google Scholar 

  4. Kui B, Balla Z, Vasas B, Végh ET, Pallagi P, Kormányos ES, Venglovecz V, Iványi B, Takács T, Hegyi P, Rakonczay Z (2015) New insights into the methodology of L-arginine-induced acute pancreatitis. PLoS One 10(2):e0117588. https://doi.org/10.1371/journal.pone.0117588

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhang H, Neuhöfer P, Song L (2013) IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality. J Clin Invest 123(3):1019–1033

    Article  CAS  Google Scholar 

  6. Maheshwari N, Kumar A, Iqbal ZA, Mandal AK, Vyas A, Wig JD (2015) Organ failure in acute pancreatitis and its impact on outcome in critical care. Southwest J Pulm Crit Care 10:253–264

  7. Campos A (2017) Plasmapheresis in the management of acute pancreatitis due to severe hypertriglyceridemia-reporting new cases. J Ren Hepat Disord 1(1):29–34

    Article  Google Scholar 

  8. Dedemadi G, Nikolopoulos M, Kalaitzopoulos I, Sgourakis G (2016) Management of patients after recovering from acute severe biliary pancreatitis. World J Gastroenterol 22(34):7708–7717

    Article  Google Scholar 

  9. Baal MC, Santvoort HC, Bollen TL, Dutch Pancreatitis Study Group (2011) Systematic review of percutaneous catheter drainage as primary treatment for necrotizing pancreatitis. BJS. 98:18–27

    Article  Google Scholar 

  10. Pezzilli R, Zerbi A, Campra D, Italian Association for the Study of the Pancreas (AISP) (2015) Consensus guidelines on severe acute pancreatitis. Dig Liver Dis 47(7):532–543

    Article  Google Scholar 

  11. Costa DW, Boerma D, van Santvoort HC (2014) Staged multidisciplinary step-up management for necrotizing pancreatitis. BJS. 101:65–79

    Article  CAS  Google Scholar 

  12. Jaswal DS, Leung JM, Sun J (2014) Tidal volume and plateau pressure use for acute lung injury from 2000 to present: a systematic literature review. Crit Care Med 42(10):2278–2289

    Article  Google Scholar 

  13. Zhou MT, Chen CS, Chen BC (2010) Acute lung injury and ARDS in acute pancreatitis: mechanisms and potential intervention. World J Gastroenterol 16(17):2094–2099

    Article  Google Scholar 

  14. Deng LH, Hu C, Cai WH (2017) Plasma cytokines can help to identify the development of severe acute pancreatitis on admission. Medicine 96(28):E7312

    Article  CAS  Google Scholar 

  15. Orlov YP, Gorova NV, Glushchenko AV (2016) Acute pancreatitis by the view of anesthesiology – reanimatology: comments to the Russian recommendations for the treatment of acute pancreatitis. Bulletin of Intensive Therapy 4:34–40

  16. Czako L, Takacs T (1998) Involvement of oxygen-derived free radicals in L-arginine-induced acute pancreatitis. Dig Dis Sci 43(8):1770–1777

    Article  CAS  Google Scholar 

  17. Bahrii VA, Dibrova (2016) Methods of morphological research: monograph / M.M. Vinnytsya: New Book

  18. Fedorkiv MB (2015) Prevention and correction of pulmonary complications for severe acute pancreatitis. Klin Khir (6):22–24 Ukrainian

  19. Korobeinykova YN (1989) Modification of the determination of lipid peroxidation products in reaction with thiobarbituric acid. Laboratory work 7:8–10

    Google Scholar 

  20. Havrylov VB, Havrylova AR, Khmara YF (1988) Measurement of diene conjugates in blood plasma by IF absorption of heptane and isopropanol extracts. Laboratory Work 2:60–63.22

    Google Scholar 

  21. Gabrielyan NI, Dmitriev AA, Kulakov GP (1981) Diagnostic value of determination of average molecules in blood plasma in nephrologic diseases. Clin Med 10:38–42

    Google Scholar 

  22. Potanina OK, Dorfman AG, Ogurtsova EV (2011) Comparison of efficiency of prognostic scales of an estimation of gravity of a condition of resuscitation patients of a surgical profile. Doctor and IT 6:50–61

    Google Scholar 

  23. Ozkardeş AB, Bozkurt B, Dumlu EG (2015) Effects of everolimus on a rat model of cerulein-induced experimental acute pancreatitis. Ulus Cerrahi Derg 31:185–191

    PubMed  PubMed Central  Google Scholar 

  24. Sargin G, Coşkum A, Akin HŞ, Karaoğlu AŐ (2013) Recurrent acute pancreatitis due to hypertriglyceridemia and acute lung injury. Istanbul Med J 14:143–145

    Google Scholar 

  25. Swaroopa D, Bhaskar K, Mahathi T (2016) Association of serum interleukin-6, interleukin-8, and Acute Physiology and Chronic Health Evaluation II score with clinical outcome in patients with acute respiratory distress syndrome. Indian J Crit Care Med 20(9):518–525

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Mariana Fedorkiv and Marco V. Marino analyzed the data and drafted the article; Mariana Fedorkiv, Roman Kuzenko, and Sergiy Gvozdyk participated in the experiment simulation and data collection; Mykola Bagrii performed histological exams, histological photography, and data collection; Galyna Shabat performed study design and manuscript revision. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Galyna Shabat.

Ethics declarations

Ethical Approval

The study was approved by the Institutional Ethical Committee of Ivano-Frankivsk National Medical University (Ivano-Frankivsk, Ukraine) and performed according to the Helsinki Declaration guidelines. (Directives EU № 609 from 24/11/1986 and the Law of Ukraine No. 3447-1 from 21/02/2006).

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fedorkiv, M., Marino, M.V., Kuzenko, R. et al. Experimental Acute Pancreatitis-Induced Lung Injury—Prevented with “Cytoflavin®”. Indian J Surg 83, 720–725 (2021). https://doi.org/10.1007/s12262-020-02475-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-020-02475-6

Keywords

Navigation